Although it is well established that BTLA mainly functions as a negative regulator of lymphocytes, recent studies indicate that the role of BTLA in tumor-resident T cells is complex, as engagement by its ligand, HVEM, inhibits proliferation and cytokine production, but promotes survival of tumor-infiltrating lymphocytes (68). The gene discussed is BTLA; the disease is neoplasm.